While the FDA may consider an emergency use authorization, a coronavirus vaccine likely won’t be accessible to the general public until next year, says Healthcare Policy Analyst Chris Meekins.
Recorded June 24, 2020.
Markets & Investing September 27, 2023 Raymond James CIO Larry Adam discusses why we were due for the...
Economy & Policy September 26, 2023 Raymond James Senior Investment Strategist Tracey Manzi discusses...
Technology & Innovation A pandemic necessity. But, how have remote preferences and hybrid workstyles...